Est. Since
2009

11

Years of Experience

35

Pivotal Projects

5,000

Volunteers

250

Investigators

30

Audits with no Critical Finding

Eminent International Advisory Panel

PROFESSOR DAVID LALLOO

Director Liverpool School of Tropical Medicine and Professor of Tropical Medicine

PROFESSOR JANE ARMITAGE

Professor of Clinical Trials and Epidemiology and Honorary Consultant in Public Health Medicine in the Nuffield Department of Population Health (NDPH) at the University of Oxford

PROFESSOR ANUSHKA PATEL

Professor of Medicine, UNSW Sydney and a cardiologist at Royal Prince Alfred Hospital in Sydney, Australia

Hands on Leadership

Samantha Ranatunga

CEO/Director

Dr. Namal Wijesinghe

Consultant/ Head of Clinical Operations

Chanaka Fernando

General Manager – Finance & Administration

Anuradha Dahanayaka

Senior Manager – Clinical Operations

Thanush Jeevarajah

Senior Manager – Business Development & Regulatory

Ingrid de Silva

Manager – Administration

Shalomi Weerawardena

Manager – Compliance & Quality Assurance

Isuru Edirisinghe

Manager – Human Resources

Rajeewa Perera

Manager – Facilities Management

Upul Ratnayaka

Manager – Information Technology

View More

Therapeutic Expertise

Oncology

Oncology

Read more

Endocrinology

Endocrinology

Read more

Immunology

Immunology

Read more

Neurology

Neurology

Read more

Gastroenterology

Gastroenterology

Read more

Cardiology

Cardiology

Read more

Ophthalmology

Ophthalmology

Read more

Toxicology

Toxicology

Read more

Infectious Diseases

Infectious-Diseases

Read more

Rare Diseases

Rare Diseases

Read more

View More

Rare Diseases

As per WHO definition a rare disease affects 1 in 2000 or fewer. There are more than 7000 rare diseases identified and most of them are linked to genetic disorders. In Sri Lanka, it is estimated that more than 2 million people live with rare diseases.

June 13, 2022

Rare Diseases Bulletin V 1.0 I 1.0

“Hope for Cure” is a quarterly bulletin focusing on rare diseases in Sri Lanka. RemediumOne as a clinical research organisation hopes to bring Sri Lankan expertes who treats orphan diseases in Sri Lanka and the […]

Read More

February 5, 2022

Acromegaly

The prevalence of acromegaly in Sri Lanka is estimated 5 in 100,000 population [Population of Sri Lanka 23 million]. Majority (90%) of the patients have facial and acral changes at the time of diagnosis. 80% […]

Read More

February 4, 2022

T1DM

Accurate incidence and prevalence data is not available in Sri Lanka. Clinical evidence and experience based unverified estimates shows prevalence of T1DM is between 1-2%. Most T1DM patients are catered by family. School system is […]

Read More

Audits & Updates

Explore All

February 5, 2022

FDA Readiness Programme

RemediumOne organised a FDA Readiness Programme for the Investigators whom we are working with. Madline Ducatte from UK conducted the training. Madline has extensive and global experience in facing FDA audits. 

Read More

February 4, 2022

First Sri Lankan ACRP (Association for Clinical Research Professionals, USA) certified CRA from RemediumOne

First Sri Lankan ACRP (Association for Clinical Research Professionals, USA) certified CRA from RemediumOne RemediumOne is proud to announce that the country’s first ACRP (Association of Clinical Research Professionals, USA) certified CRA is from RemediumOne. […]

Read More

February 3, 2022

Virtual Audit at RemediumOne

RemediumOne faced an audit carried out by the sponsor for one of its more complex and pivotal studies. It was the first experience for the company with a virtual audit carried out through an online […]

Read More

Our Collaborators

Investigators & Site Network

Investigators

Explore All

August 3, 2022

Another donation series at National Institute of Nephrology Dialysis and Transplant Unit at Maligawatta

In this critical situation our hospitals have been affected in different aspects. We thought to donate Bedsheets, Adult pampers and aluminum containers to improve patient facility at National Institute of Nephrology Dialysis and Transplant Unit […]

Read More

July 1, 2022

Donated Glucose Strips worth Rs.200,000 for the ward patients at the Institute of Cardiology, National Hospital of Sri Lanka

It’s with great pleasure of initiating donation to the Institute of Cardiology, National Hospital of Sri Lanka to help uplift the quality of medical services & ease off the distress of medicine shortage during these […]

Read More

June 15, 2022

Dr. Chula Herath, Consultant Nephrologist at Sri Jayawardenepura General Hospital has contributed immensely to nephro clinical trials in Sri Lanka.

Dr. Chula Herath, Consultant Nephrologist at Sri Jayawardenepura General Hospital has contributed immensely to nephro clinical trials in Sri Lanka. RemediumOne is privileged to work with him in number of trials over the 12 years. […]

Read More

Site Network

Explore All

Employee Engagement

June 17, 2022

Leadership Training at Belihuloya

Provided leadership training for our staff at Belihuloya with Wild Drift team. Had a productive two days and refreshed our mind and soul through the training.

Read More

June 15, 2022

Reaching Above and Beyond – The first staff meeting of the year 2022

After 8 months Remedians gathered together in April 2022 to review the organisational progress and to discuss the future prospects. It was a thoughtful and successful event with fun filled evening. Glimpse of staff gathering […]

Read More

International Clinical Trials Day 2022

As we celebrate International Clinical Trials day on 20th May, we would like to emphasize on the contribution you make towards the science and thank all of you for your effort. Let’s be proud Remedians […]

Read More

Publications

Explore All

View Publication

July 29, 2022

Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South AsianWomen With Recent Gestational Diabetes

View Publication

July 25, 2022

Desidustat in Anemia due to Non- Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)

View Publication

July 18, 2022

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

View Publication

July 12, 2022

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

View Publication

February 7, 2022

Polypills for the prevention of cardiovascular disease: a framework for wider use

View Publication

February 6, 2022

Effcay of a Tetravalent Dengue Vaccine in Healthy Children & Adolescents

View Publication

February 5, 2022

A Community-Based Intervention for Managing Hypertension in Rural South Asia